Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page, which blocks access to the study details.
    Difference
    20%
    Check dated 2026-09-21T22:37:36.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision stamp changed from v3.6.5 to v3.6.6, signaling a minor update to the site. No substantive study details or content appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-31T17:42:14.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor release update to the page's version metadata rather than a content change.
    Difference
    0.0%
    Check dated 2026-08-10T15:25:30.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.6.4) replacing the previous one, indicating a lightweight platform update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:40.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, indicating a minor maintenance update to the page's metadata. No study content or results are affected.
    Difference
    0.0%
    Check dated 2026-07-05T14:30:48.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2 in place of v3.6.0, indicating a routine site update. The change does not modify study details or interactions on the page.
    Difference
    0.0%
    Check dated 2026-06-28T08:32:31.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.